Study Pinpoints Ropivacaine Dose and Positioning Time for One-Sided Spinal Anesthesia
A sequential dose- and time-finding trial determined the median effective dose of 0.5% hyperbaric ropivacaine and the median lateral decubitus ...
A sequential dose- and time-finding trial determined the median effective dose of 0.5% hyperbaric ropivacaine and the median lateral decubitus ...
Long-term PEACE-1 trial results show that adding abiraterone to ADT and docetaxel reduced the risk of death by 32 percent ...
A first-in-human phase 1 trial at UCI Health is using padeliporfin vascular-targeted photodynamic therapy to destroy pancreatic tumors encasing major ...
A pilot study of fifteen German children with selective mutism found large reductions in parent-rated symptom severity and a remission ...
A prospective trial found constitutional pathogenic variants in about 10 percent of solid tumor patients screened through comprehensive cancer genome ...
A randomised German trial found oral D-β-hydroxybutyrate ester was well tolerated in ALS patients and showed preliminary adjusted effects on ...
A vitamin B5 derivative called pantethine suppressed dendritic cell hyperactivation, prevented psoriasis in mice and improved symptoms in a small ...
A randomized controlled trial in gynecological laparoscopic surgery patients found that injecting granisetron at the PC6 wrist acupoint significantly reduced ...
A phase 3 trial shows sacituzumab tirumotecan significantly lowers the risk of cancer progression and death in women with recurrent ...
The DILICORT trial, the first randomized double-blind placebo-controlled study of prednisone in acute idiosyncratic drug-induced liver injury, will enroll sixty ...
An NIH-funded phase 1/2 trial will test whether JAK inhibitors can protect pancreatic insulin-producing cells in people who develop diabetes ...
A clinical trial of more than 500 cancer survivors found that mindfulness and tai chi or qigong improved pain interference, ...
The 35,878-person PATHFINDER 2 trial found 6.5-fold more cancers when Galleri was added to routine screening, but it did not ...
In the first randomised placebo-controlled phase 3 factorial trial for post-COVID-19 syndrome, a 28-day course of low-dose prednisolone significantly reduced ...
Henry Ford Health has enrolled the first US patients in a global clinical trial evaluating pulmonary artery denervation for pulmonary ...
The FDA granted accelerated approval for dostarlimab in adults with stage II or III locally advanced rectal cancer whose tumors ...
The NIH-funded BabyMERIT trial will test trametinib in 25 infants with severe hypertrophic cardiomyopathy associated with Noonan syndrome and related ...
A 36-participant randomized trial found no statistically significant clinical benefit from 0.12% Centella asiatica mouthwash after mandibular third molar surgery.
A published protocol describes a planned first-in-human trial of an investigational product: an autologous chimeric antigen receptor T-cell therapy designed ...
The new phase 3 RxFINE-Low trial will test whether patients with low genomic risk but high anatomic risk early-stage breast ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.